AbbVie, the contract manufacturing business of Abbott, offers manufacturing services for biologics, potent, drug product and bulk active pharmaceutical ingredients .
Through its rich heritage from its predecessor, AbbVie has been in the business of developing and producing pharmaceutical products for more than 120 years. Over 25 years, we have offered Contract Manufacturing to provide customers with high-quality, innovative, cost-effective services in the area of Biologics, Potent, Drug Product and Bulk Active Pharmaceutical Ingredients to benefit the companies that put their trust in us.
Learn more about our services by visiting www.abbviecontractmfg.com.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.